Last $194.72 USD
Change Today +1.95 / 1.01%
Volume 704.5K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ann M. Veneman J.D.

Director, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 4 different organizations across 3 different industries.

See Board Relationships
65$430,635

Background*

Ms. Ann M. Veneman, J.D., served as the 27th Secretary of the United States Department of Agriculture from 2001 to 2005. Ms. Veneman has been a Director at Alexion Pharmaceuticals, Inc. since May 28, 2010. Ms. Veneman has been a Non-Executive Director of Nestlé S.A. since April 14, 2011. She has been a Director of S&W Seed Company since December 2013. She serves as a Director at Malaria No More. She chairs the United Nations' Standing Committee on Nutrition and the board ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Director
2010-Present
Director, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
2011-Present
Non-Executive Director and Member of Nomination Committee
2013-Present
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

Master's Degree 1971
University of California Berkeley
Honorary Doctorate 2007
Middlebury College
Bachelor's Degree 1970
University of California, Davis
Honorary Doctorate 2004
Delaware State University
JD 1976
Hastings College of Law
Honorary Doctorate 2003
Lincoln University of Missouri
Honorary Doctorate 2001
California Polytechnic State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$85,000
Total Calculated Compensation$430,635
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $194.72 USD +1.95

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Stephen Edward Foots Chief Executive Officer, Executive Director, Chairman of Group Executive Committee, Member of Risk Management Committee, Member of Routine Business Committee, Member of Nomination Committee, Member of Finance Committee and Member of Group Safety, Health & Environment Steering Committee
Croda International plc
535.0K GBP
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.